Stocktoria
Compass Therapeutics, Inc. CMPX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-11-13
Compass Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 6,613,637 | $6.6M |
| CITADEL ADVISORS LLC | 891,110 | $4.7M |
| MILLENNIUM MANAGEMENT LLC | 846,220 | $4.5M |
| AQR CAPITAL MANAGEMENT LLC | 200,428 | $1.1M |
| D. E. Shaw & Co., Inc. | 65,967 | $348,965 |
| TWO SIGMA INVESTMENTS, LP | 33,100 | $175,099 |
Source: SEC EDGAR filings · CIK 0001738021 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.